{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:46Z","timestamp":1787890006284,"version":"build-2784847793"},"reference-count":188,"publisher":"American Chemical Society (ACS)","issue":"6","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-001"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-009"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"}],"funder":[{"name":"School of Pharmacy, Chapman University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2021,6,7]]},"DOI":"10.1021\/acs.molpharmaceut.0c01239","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T20:30:04Z","timestamp":1620160204000},"page":"2105-2121","source":"Crossref","is-referenced-by-count":45,"title":["siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses"],"prefix":"10.1021","volume":"18","author":[{"given":"Muhammad Imran","family":"Sajid","sequence":"first","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"},{"name":"Faculty of Pharmacy, University of Central Punjab, Lahore 54700, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Moazzam","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Central Punjab, Lahore 54700, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeseom","family":"Cho","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"},{"name":"Department of Biochemistry and Molecular Biology, Schmid College of Science and Technology, Chapman University, Orange, California 92866, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kato","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"},{"name":"Department of Biochemistry and Molecular Biology, Schmid College of Science and Technology, Chapman University, Orange, California 92866, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Way","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Lohan","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-4548","authenticated-orcid":true,"given":"Rakesh K.","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, California 92618, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"ref1\/cit1","unstructured":"WorldoMeter. COVID-19 Coronavirus Pandemic. https:\/\/www.worldometers.info\/coronavirus\/ (2021-04-30)."},{"key":"ref2\/cit2","unstructured":"WHO.  Coronavirus Disease (COVID-19) Situation Report 120, May 20, 2020."},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.3390\/v12040372"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.07.937862"},{"key":"ref5\/cit5","volume-title":"The Wall Street Journal","author":"Hernandez D.","year":"2021"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.01.015"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3143"},{"key":"ref8\/cit8","unstructured":"CDC. COVID-19 Treatment Guidelines. https:\/\/covid19treatmentguidelines.nih.gov\/introduction\/ (accessed 2021-02-11)."},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1038\/35888"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171251798"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1038\/35078107"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.7150\/thno.9404"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1038\/nature00873"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/nature00896"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1038\/nm725"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-1-34"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0502-500"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.37"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1007\/s10123-020-00146-w"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2019.04.012"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01269-0"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.03.027"},{"key":"ref23\/cit23","volume-title":"AJMC","author":"Davio K.","year":"2019"},{"key":"ref24\/cit24","unstructured":"ClinicalTrials.gov. A Study to Evaluate Lumasiran in\nChildren and Adults With Primary Hyperoxaluria Type 1 (ILLUMINATE-A), 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03681184 (accessed 2021-04-19)."},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S159297"},{"key":"ref26\/cit26","unstructured":"ClinicalTrials.gov. Study of Fitusiran (ALN-AT3SC) in\nSevere Hemophilia A and B Patients Without Inhibitors, 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03417245 (accessed 2021-03-04)."},{"key":"ref27\/cit27","unstructured":"ClinicalTrials.gov. HELIOS-B: A Study to Evaluate Vutrisiran\nin Patients With Transthyretin Amyloidosis With Cardiomyopathy, 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04153149 (accessed 2021-04-19)."},{"key":"ref28\/cit28","volume-title":"BioSpace","author":"Alnylam Pharmaceuticals","year":"2020"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.02.019"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2020.0868"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.17179\/excli2020-1328"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_115_20"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8050109"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00916"},{"key":"ref35\/cit35","doi-asserted-by":"crossref","DOI":"10.1038\/nature02872","volume-title":"Revealing the World of RNA Interference","author":"Mello C. C.","year":"2004"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90082-9"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0004(93)90137-C"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90050-3"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5462.2494"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80531-0"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1101\/gad.862301"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1038\/418038a"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.2307\/1588476"},{"key":"ref44\/cit44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-819400-3.00007-7","volume-title":"Emerging and Reemerging Viral Pathogens","author":"Kasmi Y.","year":"2020"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000188166.17324.60"},{"key":"ref46\/cit46","unstructured":"World Health Organization.  Coronavirus\nNever before\nSeen in Humans Is the Cause of SARS, April 16, 2003."},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45053"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.02.003"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1976"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.03.194"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.embor840"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252783999"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-016-0747-8"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.1.810-812.2003"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(03)00170-9"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0235524100"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2004.01.011"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1186\/1479-0556-2-8"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.14.7523-7527.2004"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402486101"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1093\/embo-reports\/kvf234"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.14.7763-7774.2004"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2004.01.014"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.5.3301-3306.2003"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.19.10276-10281.2004"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00244-2"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840380410"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-004-4111-2"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1472231"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1038\/nbt824"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.3390\/v4060980"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.10.004"},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302479"},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085952"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085953"},{"key":"ref77\/cit77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-981-15-4814-7_3","volume-title":"Coronavirus Disease 2019 (COVID-19)","author":"Kumar S.","year":"2020"},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104260"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300520200"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145"},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.11.7195-7206.2005"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02744-05"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00415-08"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-00210-0"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.3390\/v12050491"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202000047"},{"issue":"3","key":"ref88\/cit88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/135965350400900310","volume":"9","author":"Zheng B.-j.","year":"2004","journal-title":"Antiviral Therapy"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.10.008"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.23.6877"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2004.09.005"},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.20.2665"},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290286"},{"key":"ref94\/cit94","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2020-0162"},{"key":"ref95\/cit95","doi-asserted-by":"publisher","DOI":"10.1038\/nm1280"},{"key":"ref96\/cit96","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.05.976167"},{"key":"ref97\/cit97","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206658"},{"key":"ref98\/cit98","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.114493"},{"key":"ref99\/cit99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2010.11.021"},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00440-09"},{"key":"ref101\/cit101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.027"},{"key":"ref102\/cit102","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4"},{"key":"ref103\/cit103","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.05.001"},{"key":"ref105\/cit105","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46691"},{"key":"ref106\/cit106","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-00217-2"},{"key":"ref107\/cit107","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17165904"},{"key":"ref108\/cit108","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15652"},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(04)00087-0"},{"key":"ref110\/cit110","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-020-00221-6"},{"key":"ref111\/cit111","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198114"},{"key":"ref112\/cit112","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00370-6"},{"key":"ref113\/cit113","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7003e2"},{"key":"ref114\/cit114","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.21.20248640v1"},{"key":"ref115\/cit115","unstructured":"CDC. Emerging SARS-CoV-2\nVariants. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/more\/science-and-research\/scientific-brief-emerging-variants.html (accessed 2021-02-27)."},{"key":"ref116\/cit116","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01285-x"},{"key":"ref117\/cit117","unstructured":"Faria, N. R.; Claro, I. M.; Candido, D.; Moyses Franco, L.; Andrade, P. S.; Coletti, T. M.; Silva, C. A. M.; Sales, F. C.; Manuli, E. R.; Aguiar, R. S.;  Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings, 2021. https:\/\/virological.org\/t\/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings\/586 (accessed 2021-01-12)."},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg9559"},{"key":"ref120\/cit120","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32466-1"},{"key":"ref121\/cit121","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"ref122\/cit122","unstructured":"Janssen\nBiotech, Inc. COVID-19 Vaccine Ad26.COV2.S, February\n26, 2021. https:\/\/www.fda.gov\/media\/146219\/download (accessed 2021-02-26)."},{"key":"ref123\/cit123","unstructured":"ClinicalTrials.gov. A Study of Ad26.COV2.S for the Prevention\nof SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04505722 (accessed 2021-03-04)."},{"key":"ref124\/cit124","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31605-6"},{"key":"ref125\/cit125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31866-3"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30831-8"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.09.285445"},{"key":"ref128\/cit128","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30843-4"},{"key":"ref129\/cit129","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.15543"},{"key":"ref130\/cit130","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026920"},{"key":"ref131\/cit131","unstructured":"Sanofi. Sanofi and GSK Announce a Delay in Their Adjuvanted Recombinant\nProtein-based COVID-19 Vaccine Program to Improve Immune Response\nin the Elderly, December 14, 2020. https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2020\/2020-12-11-07-00-00 (accessed 2021-01-07)."},{"key":"ref132\/cit132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102743"},{"key":"ref133\/cit133","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2032195"},{"key":"ref134\/cit134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"ref135\/cit135","unstructured":"ClinicalTrials.gov. A Study to Evaluate the Safety, Reactogenicity\nand Immunogenicity of Vaccine CVnCoV in Healthy Adults. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=&term=NCT04449276&cntry=&state=&city=&dist (accessed 2020-12-14)."},{"key":"ref136\/cit136","unstructured":"ISRCTN. Clinical trial to assess the safety of a coronavirus\nvaccine in healthy men and women. http:\/\/www.isrctn.com\/ISRCTN17072692 (accessed 2020-12-14)."},{"key":"ref137\/cit137","unstructured":"ClinicalTrials.gov. Ascending Dose Study of Investigational\nSARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=&term=NCT04480957&cntry=&state=&city=&dist (accessed 2020-12-14)."},{"key":"ref138\/cit138","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.056"},{"key":"ref139\/cit139","unstructured":"ClinicalTrials.gov. Safety, Tolerability and Immunogenicity\nof INO-4800 for COVID-19 in Healthy Volunteers. https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=&term=NCT04336410&cntry=&state=&city=&dist (accessed 2020-12-14)."},{"key":"ref140\/cit140","unstructured":"Wang, Y.; Liu, L.; Wang, S.; Zhang, Y. Small interfering RNA for restraining SARS corona virus M protein gene expression, encoding gene and application thereof. CN101173275, 2008."},{"key":"ref141\/cit141","unstructured":"Fukuda, N.; Ueno, T.; Fukushima, A.; Kuroda, K. Ribozyme to cleave coronavirus gene. U.S. Patent 20100273997, 2010."},{"key":"ref142\/cit142","doi-asserted-by":"publisher","DOI":"10.1159\/000215946"},{"key":"ref143\/cit143","unstructured":"McSwiggen, J.; Beigelman, L. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid. U.S. Patent 20040192626, 2012."},{"key":"ref144\/cit144","unstructured":"McSwiggen, J.; Chowrira, B.; Beigelman, L.; Macejak, D.; Zinnen, S.; Pavco, P.; Haeberli, P.; Morissey, D.; Fosnaugh, K.; Jamison, S. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA). U.S. Patent 20050020525, 2005."},{"key":"ref145\/cit145","unstructured":"McSwiggen, J.; Chowrira, B.; Haeberli, P. Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (SARS) Gene Expression Using Short Interfering Nucleic Acid. WO200409238, 2007."},{"key":"ref146\/cit146","unstructured":"Elm\u00e9n, J.; Wahlestedt, C.; Liang, Z.; S\u00f8rensen, A. M. \u00d8rum, H.; Koch, T. Short interfering RNA (siRNA) analogues. U.S. Patent 8,653,252, 2014."},{"key":"ref147\/cit147","unstructured":"Sun, B.; Zheng, B.; Lu, W.; Xu, K. SARS coronavirus disturbance RNA and its uses. CN101085986, 2006"},{"key":"ref148\/cit148","unstructured":"Zhang, Y.; Wang, G.; Li, M.; Wang, H.; Feng, H. siRNA disturbing RdRp gene function of SARS virus. CN101113158, 2006."},{"key":"ref149\/cit149","unstructured":"Wang, Y; Liu, L.; Wang, S; Zhang, Y. Small interfering RNA for restraining SARS corona virus M protein gene expression, encoding gene and application thereof. CN101173275, 2006."},{"key":"ref150\/cit150","unstructured":"Li, B.; Lu, Y.; Cheng, D. Multi-target point cocktail double strand small interfere RNA used for curing disease and method of producing same. CN101182517, 2007."},{"key":"ref151\/cit151","unstructured":"Ping, M.; Ning, Y. PI4KB siRNA and application thereof to preparation of medicament for inhibiting SARS-CoV infection. CN102453712, 2010."},{"key":"ref152\/cit152","unstructured":"Wu, X.; Wu, H. Coronary virus RNA interference preparation for severe acute respiratory syndrome pathogen. CN1458281, 2003."},{"key":"ref153\/cit153","unstructured":"Ji, F.; Luo, L. siRNA target sequence bank of SARS virus and use thereof. CN1465584, 2003."},{"key":"ref154\/cit154","unstructured":"Hou, W.; Shen, L.; Lu, A. Medicine for preventing and treatig SARS coronavirus. CN1548054, 2003."},{"key":"ref155\/cit155","unstructured":"Yin, D.; Yin, Q. Method for manufacturing gene medicine for preventing and treating SARS and its medicinal prescription. CN1569233, 2003."},{"key":"ref156\/cit156","unstructured":"Liu, J.; Song, X. siRNA nucleic acid sequence for SARS coronavirus causing gene and its pharmaceutical use. CN1569878, 2003."},{"key":"ref157\/cit157","unstructured":"Ding, J. Small interference RNA molecule (siRNA) of attacking SARS virus mRNA molecule and application. CN1590545, 2003."},{"key":"ref158\/cit158","unstructured":"Chen, Y.; Wang, Z.; Wang, J. SARS virus resisting siRNA and its application. CN1609116, 2003."},{"key":"ref159\/cit159","unstructured":"Chen, Y.; Wang, Z.; Wang, J. SARS virus resisting siRNA and its application. CN1609117, 2003."},{"key":"ref160\/cit160","unstructured":"Jin, Y.; Shi, Y. I.; Luo, H. Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression. CN1648249, 2004."},{"key":"ref161\/cit161","unstructured":"Yeung, A. W. H. Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro. EP1482037, 2006."},{"key":"ref162\/cit162","unstructured":"Takebe, Y.; Naito, T.; Saigo, K.; Natori, Y. Method for designing RNA interference polynucleotide mixture, device for designing RNA interference polynucleotide mixture, method for producing RNA interference polynucleotide mixture, program for designing RNA interference polynucleotide mixture and RNA interference polynucleotide mixture. JP2006238724, 2005."},{"key":"ref163\/cit163","unstructured":"Tanuma, Y.; Shimizu, M. Inhibitor on endocytosis-dependent DNA uptake, promoter on endocytosis-dependent DNA uptake, virus infection inhibitor, virus infection preventing agent, and virus infection promoter as well as genetic marker, monoclonal antibody, hybridoma and method of using the same. JP2008253188, 2007."},{"key":"ref164\/cit164","unstructured":"Kung, H.F.; He, M.L.; Zheng, B.J.; Guan, Y.; Lin, M. C.M.; Peng, Y. Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference. U.S. Patent 20050004063, 2006."},{"key":"ref165\/cit165","unstructured":"Tang, Q. Q.; Lu, P. Y.; Xie, F. Y.; Liu, Y.; Xu, J.; Woodle, M. C. RNAi agents for anti-sars coronavirus therapy. WO2005019410, 2005."},{"key":"ref166\/cit166","unstructured":"Lu, P. Y.; Simonenko, V.; Cai, Y.; Xu, J.; Evans, D. siRNA\/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral Infection. WO2017044507, 2019."},{"key":"ref167\/cit167","unstructured":"Jin, G. The palindrome and complementary palindrome tiny RNA and its application. CN107488660, 2017."},{"key":"ref168\/cit168","unstructured":"Iversen, P. L. Sense antiviral compound and method for treating ssRNA viral infection. WO2005013905, 2004."},{"key":"ref169\/cit169","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00272"},{"key":"ref170\/cit170","unstructured":"Stein, D.; Skilling, D.; Iversen, P.; Smith, A., Antisense antiviral agent and method for treating ssRNA viral infection. U.S. Patent 20030224353170, 2003."},{"key":"ref171\/cit171","doi-asserted-by":"publisher","DOI":"10.3390\/ph13100294"},{"key":"ref172\/cit172","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.066399"},{"key":"ref173\/cit173","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9210-4"},{"key":"ref174\/cit174","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0017-4"},{"key":"ref175\/cit175","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.01.042"},{"key":"ref176\/cit176","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300240"},{"key":"ref177\/cit177","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp106"},{"key":"ref178\/cit178","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-3112-5","volume-title":"siRNA Delivery Methods","author":"Shum K.","year":"2016"},{"key":"ref179\/cit179","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.36"},{"key":"ref180\/cit180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02989-4"},{"key":"ref181\/cit181","doi-asserted-by":"publisher","DOI":"10.1038\/nbt936"},{"key":"ref182\/cit182","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.4"},{"key":"ref183\/cit183","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3802"},{"key":"ref184\/cit184","doi-asserted-by":"publisher","DOI":"10.1038\/srep32301"},{"key":"ref185\/cit185","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2018.29001.dow"},{"key":"ref186\/cit186","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102239"},{"key":"ref187\/cit187","unstructured":"ClinicalTrials.gov. Study to Describe the Safety, Tolerability,\nImmunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19\nin Healthy Individuals, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04368728 (accessed 2021-04-12)."},{"key":"ref188\/cit188","unstructured":"ClinicalTrials.gov. Safety and Immunogenicity Study of\n2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection\n(COVID-19), 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04283461 (accessed 2021-04-28)."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c01239","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c01239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T16:57:44Z","timestamp":1682441864000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.0c01239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":188,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,7]]}},"alternative-id":["10.1021\/acs.molpharmaceut.0c01239"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01239","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}